Precise execution

MC Services is...

Client News

… an international Corporate Communications and Investor Relations firm providing high-level consultancy with targeted services and support for transaction-oriented assignments throughout Europe and the United States.

read more

MC Services further expands its financial communications expertise with the appointment of Fabian Lorenz as a senior consultant

MC Services, the internationally active Investor Relations and Public Relations agency, announced today that Fabian Lorenz has joined the Düsseldorf office to broaden the team’s financial communications expertise as a senior consultant.

view profile


MC Services attends German Biotech Days 2015 from 22.-23. April 2015

The German Biotech Days (Deutsche Biotechnologietage) are the annual networking event for the German biotechnology industry taking place in Cologne from April 22 to 23. We are looking forward to seeing you there. If you would like to schedule a meeting, please contact us.


MC Services HealthCare Forum at Munich Capital Market Conference on May 21, 2015

MC Services once again participates in the 19th Munich Capital Market Conference (MKK – Münchner Kapitalmarkt Konferenz) from May 20 to 21, 2015. The conference is organized by GBC AG and today represents the biggest investor and analyst conference in Southern Germany. A total of 32 companies will present themselves to investors and journalists. In this context, MC Services will, for the fifth time, host the HealthCare Forum, presenting five healthcare companies to institutional generalists and small & mid cap investors and the financial media. The following companies are going to present at the MC Services HealthCare Forum:

Affimed N.V.
MagForce AG
amp biosimilars AG

Please also follow us on Twitter (@MCServicesAG).


read more

MagForce AG Installs Fifth NanoActivator(R) in Germany for the Treatment of Brain Tumors at Frankfurt University Hospital


Industriegemeinschaft Geretsried e.V. und Asylplus e.V. wollen Asylbewerbern Perspektive durch Bildung bieten


Nextech Invest New Portfolio Company Jounce Therapeutics Raises US$ 56 million in Oversubscribed Series B Financing


Results of Heidelberg Pharma’s research cooperation with M.D. Anderson Cancer Center published in Nature journal


Transgene Presents New Data with TG1050, an Immunotherapy Being Developed to Treat Chronic Hepatitis B, at The International Liver Congress™ 2015


Transgene Reports First Quarter 2015 Financial Results


SYGNIS to host Conference Call on April 29, 2015 to present Annual Results 2014


SYGNIS appoints Dr. Miguel-Antonio Viribay as
Vice President Sales and Marketing


ERYTECH strengthens its intellectual property position in the US


Professor Alain Marty appointed Chief Science Officer at Carbios


Clinical data of Medigene's dendritic cell (DC) vaccines presented at AACR conference


Transgene Presents New Pre-Clinical Data at AACR on (i) the Combination of TG4010 with Immune Checkpoint Inhibitors; (ii) TG3003, an Anti-CD115 Monoclonal Antibody